After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, ANAB falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of AnaptysBio Inc is $513.67M. A total of 0.69 million shares were traded on the day, compared to an average of 991.89K shares.
Insider Activity
Aside from predicting where a stock will go, investors also consider insider trades as an indicator of the stock’s future direction. During the recent three months, ANAB has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 0 BUYs and 0 SELLs from insiders. Insiders purchased 0 shares during that period but sold 0.
In the most recent transaction, EcoR1 Capital, LLC bought 65,184 shares of ANAB for 12.92 per share on Dec 30 ’24. After the transaction, the Director now owns 7,860,180 company shares. In a previous transaction on Dec 31 ’24, EcoR1 Capital, LLC bought 13,268 shares at 12.93 per share. ANAB shares that Director owns now total 7,873,448.
Among the insiders who bought shares, EcoR1 Capital, LLC acquired of 6,646 shares on Jan 02 ’25 at a per-share price of $12.95. This resulted in the Director holding 7,880,094 shares of ANAB after the transaction. In another insider transaction, RENTON HOLLINGS sold 10,000 shares at $25.00 per share on Nov 29 ’24. Company shares held by the Director now total 1,950.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for ANAB in the last 3 months, the mean price target is $37.64 with high estimates of $57.00 and low estimates of $18.00. In terms of 52-week highs and lows, ANAB has a high of $41.31 and a low of $12.21.
As of this writing, ANAB has an earnings estimate of -$1.46 per share for the current quarter. EPS was calculated based on a consensus of 6.0 estimates, with a high estimate of -$1.08 per share and a lower estimate of -$1.65.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. ANAB’s latest balance sheet shows that the firm has $548.10M in Cash & Short Term Investments as of fiscal 2021. There were $20.95M in debt and $16.10M in liabilities at the time. Its Book Value Per Share was $2.33, while its Total Shareholder’s Equity was $356.43M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ANAB is Buy with a score of 4.50.
